• 1. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 2. Achieving excellent anti-corrosion and tribological performance by tailoring the surface morphology and chemical composition of aluminum alloys
  Wenjie Zhao,Hua Hou,Yuchun Jin,Zhixiang Zeng,Xuedong Wu,Qunji Xue RSC Adv., 2014,4, 60307-60315
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Phthalic acid and derivatives

Recent Advances in the Research of Dimethyl 4-hydroxyisophthalate (CAS: 5985-24-0)

Dimethyl 4-hydroxyisophthalate (CAS: 5985-24-0) is a key intermediate in the synthesis of various pharmaceuticals, agrochemicals, and specialty chemicals. Recent studies have highlighted its significance in the development of novel therapeutic agents and advanced materials. This research briefing aims to provide an overview of the latest advancements related to this compound, focusing on its synthesis, applications, and biological activities.

One of the most notable developments in the field is the optimization of synthetic routes for Dimethyl 4-hydroxyisophthalate. Researchers have reported improved catalytic methods that enhance yield and purity while reducing environmental impact. For instance, a 2023 study published in the Journal of Organic Chemistry demonstrated a green chemistry approach using heterogeneous catalysts, achieving a yield of over 90% under mild reaction conditions. This advancement is particularly relevant for industrial-scale production.

In the pharmaceutical sector, Dimethyl 4-hydroxyisophthalate has been investigated as a precursor for the synthesis of anti-inflammatory and anticancer agents. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) explored its role in the development of COX-2 inhibitors, showing promising results in preclinical models. The compound's unique structural features enable the design of molecules with high selectivity and reduced side effects.

Another area of interest is the application of Dimethyl 4-hydroxyisophthalate in polymer chemistry. Its incorporation into polyester and polyamide backbones has been shown to enhance material properties such as thermal stability and biodegradability. A 2023 paper in Polymer Chemistry highlighted its use in the synthesis of high-performance polymers for medical devices, underscoring its versatility.

From a biological perspective, recent research has shed light on the compound's potential as a bioactive molecule. Studies have indicated that derivatives of Dimethyl 4-hydroxyisophthalate exhibit antimicrobial and antioxidant properties, making them candidates for further drug development. However, more in vivo studies are needed to fully understand their pharmacokinetics and safety profiles.

In conclusion, Dimethyl 4-hydroxyisophthalate (CAS: 5985-24-0) continues to be a compound of significant interest in chemical, pharmaceutical, and materials research. The latest studies underscore its potential in diverse applications, from drug discovery to advanced materials. Future research should focus on scaling up production methods and exploring new therapeutic avenues to fully harness its capabilities.

• 119-36-8(Methyl salicylate)
• 90045-28-6(Gaultheria procumbens extract)
• 68917-75-9(wintergreen oil from gaultheria procumbens L.)
• 8024-54-2(Methyl salicylate)
• 22717-57-3(Methyl 2-hydroxy-5-methylbenzoate)
• 23287-26-5(Methyl 2-hydroxy-3-methylbenzoate)
• 29468-36-8(Benzoic acid, hydroxy-,methyl ester)
• 68917-05-5(Methyl salicylate)
• 41489-76-3(Methyl 5-Formyl-2-hydroxybenzoate)
• 8001-88-5(Birch Oil)